Exclusive enteral nutrition and infliximab combination therapy are superior to monotherapy in inducing endoscopic response in active adult Crohn’s disease
Therapeutic Advances in Gastroenterology
Published online on May 07, 2026
Abstract
Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.
Background:Anti-tumor necrosis factor alpha (anti-TNFα) agents assume a significant role in the management of Crohn’s disease (CD). Exclusive enteral nutrition (EEN) is as effective as corticosteroids for inducing remission in children with active CD, but ...
Background:Anti-tumor necrosis factor alpha (anti-TNFα) agents assume a significant role in the management of Crohn’s disease (CD). Exclusive enteral nutrition (EEN) is as effective as corticosteroids for inducing remission in children with active CD, but ...